Cargando…

RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency

 : 5α-reductase type 2 (5αR2) deficiency is an autosomal recessive inherited condition affecting 46,XY individuals resulting from the inability to convert testosterone into dihydrotestosterone. Affected individuals present a range of external genitalia undervirilization at birth and pronounced mascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Rafael Loch, Domenice, Sorahia, Mendonca, Berenice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625474/
http://dx.doi.org/10.1210/jendso/bvac150.1320
_version_ 1784822505771368448
author Batista, Rafael Loch
Domenice, Sorahia
Mendonca, Berenice
author_facet Batista, Rafael Loch
Domenice, Sorahia
Mendonca, Berenice
author_sort Batista, Rafael Loch
collection PubMed
description  : 5α-reductase type 2 (5αR2) deficiency is an autosomal recessive inherited condition affecting 46,XY individuals resulting from the inability to convert testosterone into dihydrotestosterone. Affected individuals present a range of external genitalia undervirilization at birth and pronounced masculinization at puberty. Unlike most other 46,XY DSD, the frequency of gender change among 5αR2 deficiency is high. OBJECTIVE: to analyze the 451 individuals carrying pathogenic 5αR2 variants in the SRD5A2 gene in both alleles (in homozygous or compound heterozygous state) in the literature (Pubmed, EMBASE, Medline) and websites (ensemble, HGMD, ClinVar) regarding sex assignment, external genitalia virilization (1-5 Sinnecker score), and gender change accordingly country income METHODS: A total of 357 cases out of 451 had clinical information. All patients included were divided between those born before or after 2006 (the DSD consensus year). Country income was based on the 2018 World Bank classification, classifying income into four categories: low, lower-middle, upper-middle, and high (www.worldbank.org). Categorical variables were analyzed using the Chi-square test followed by the Cramer's V. Continuous variables were analyzed either by Student t-test or ANOVA one way. A binary logistic regression was built using sex assignment and gender change as categorical dependent variables. A p<.05 was considered significant. RESULTS: When we divided the individuals into those diagnosed after and before 2006, the percentage of female sex assignments dropped from 72% to 56% (p<.0001), followed by an odds ratio reduction (from 2.52 to 1.65) for female sex assignment. Country income did not impact sex assignment (p=.21). However, most cases (86%) were reported from countries with high and upper-middle economies. The absence of reports from low-income countries may be due to several reasons, such as barriers to molecular diagnosis, scientific access, and specialized medical assistance. Most cases were assigned as female (69%). The overall rate of gender change was 25% (89 out 357). All but one changed their gender from female to male. The rate of gender change was significantly different across all countries (V=0.46; p<.001), but it ranged from 16% to 70%, and gender change was lower among those diagnosed after 2006 (p=.01). The association between less external genitalia virilization and female sex assignment was significant (p<.001). On the other hand, the virilization score was similar between those who kept or changed gender (p=.37). Neither the type of SRD5A2 variant (missense, nonsense, indel) nor zygosity (homo/hetero) impacted sex assignment or gender change. CONCLUSION: An apparent temporal trend indicates an increased likelihood of affected 5αR2 deficiency individuals being raised as boys, providing a gender change drop. The external virilization degree influenced sex assignment, but it does not affect gender change. There is no correlation between either both sex assignment and gender development with 5αR2 genetics. Presentation: Saturday, June 11, 2022 1:06 p.m. - 1:11 p.m., Saturday, June 11, 2022 1:06 p.m. - 1:11 p.m., Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.
format Online
Article
Text
id pubmed-9625474
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96254742022-11-14 RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency Batista, Rafael Loch Domenice, Sorahia Mendonca, Berenice J Endocr Soc Pediatric Endocrinology  : 5α-reductase type 2 (5αR2) deficiency is an autosomal recessive inherited condition affecting 46,XY individuals resulting from the inability to convert testosterone into dihydrotestosterone. Affected individuals present a range of external genitalia undervirilization at birth and pronounced masculinization at puberty. Unlike most other 46,XY DSD, the frequency of gender change among 5αR2 deficiency is high. OBJECTIVE: to analyze the 451 individuals carrying pathogenic 5αR2 variants in the SRD5A2 gene in both alleles (in homozygous or compound heterozygous state) in the literature (Pubmed, EMBASE, Medline) and websites (ensemble, HGMD, ClinVar) regarding sex assignment, external genitalia virilization (1-5 Sinnecker score), and gender change accordingly country income METHODS: A total of 357 cases out of 451 had clinical information. All patients included were divided between those born before or after 2006 (the DSD consensus year). Country income was based on the 2018 World Bank classification, classifying income into four categories: low, lower-middle, upper-middle, and high (www.worldbank.org). Categorical variables were analyzed using the Chi-square test followed by the Cramer's V. Continuous variables were analyzed either by Student t-test or ANOVA one way. A binary logistic regression was built using sex assignment and gender change as categorical dependent variables. A p<.05 was considered significant. RESULTS: When we divided the individuals into those diagnosed after and before 2006, the percentage of female sex assignments dropped from 72% to 56% (p<.0001), followed by an odds ratio reduction (from 2.52 to 1.65) for female sex assignment. Country income did not impact sex assignment (p=.21). However, most cases (86%) were reported from countries with high and upper-middle economies. The absence of reports from low-income countries may be due to several reasons, such as barriers to molecular diagnosis, scientific access, and specialized medical assistance. Most cases were assigned as female (69%). The overall rate of gender change was 25% (89 out 357). All but one changed their gender from female to male. The rate of gender change was significantly different across all countries (V=0.46; p<.001), but it ranged from 16% to 70%, and gender change was lower among those diagnosed after 2006 (p=.01). The association between less external genitalia virilization and female sex assignment was significant (p<.001). On the other hand, the virilization score was similar between those who kept or changed gender (p=.37). Neither the type of SRD5A2 variant (missense, nonsense, indel) nor zygosity (homo/hetero) impacted sex assignment or gender change. CONCLUSION: An apparent temporal trend indicates an increased likelihood of affected 5αR2 deficiency individuals being raised as boys, providing a gender change drop. The external virilization degree influenced sex assignment, but it does not affect gender change. There is no correlation between either both sex assignment and gender development with 5αR2 genetics. Presentation: Saturday, June 11, 2022 1:06 p.m. - 1:11 p.m., Saturday, June 11, 2022 1:06 p.m. - 1:11 p.m., Monday, June 13, 2022 12:30 p.m. - 2:30 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9625474/ http://dx.doi.org/10.1210/jendso/bvac150.1320 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Pediatric Endocrinology
Batista, Rafael Loch
Domenice, Sorahia
Mendonca, Berenice
RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency
title RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency
title_full RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency
title_fullStr RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency
title_full_unstemmed RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency
title_short RF02 | PMON189 Temporal and Social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency
title_sort rf02 | pmon189 temporal and social trends towards sex assignment and gender change in the 5α-reductase type 2 deficiency
topic Pediatric Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625474/
http://dx.doi.org/10.1210/jendso/bvac150.1320
work_keys_str_mv AT batistarafaelloch rf02pmon189temporalandsocialtrendstowardssexassignmentandgenderchangeinthe5areductasetype2deficiency
AT domenicesorahia rf02pmon189temporalandsocialtrendstowardssexassignmentandgenderchangeinthe5areductasetype2deficiency
AT mendoncaberenice rf02pmon189temporalandsocialtrendstowardssexassignmentandgenderchangeinthe5areductasetype2deficiency